ARCHIVES

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

This article is from The Cancer Letter archive.

Vol. 33 No. 06 | February 16, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999

Finally, An FY01 Appropriation For NIH; NCI’s Share $3.757 Billion, A 13.5% Raise.

January 5, 2001

DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off

June 1, 2001

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

NCI Payline In 1985 Likely To Be 170; $5.9 Million To Be Diverted to AIDS

December 7, 1984